Howard Sklamberg, drugs compliance director at US FDA, takes on global role at agency
This article was originally published in SRA
Executive Summary
Howard Sklamberg, the director of the Office of Compliance at the US Food and Drug Administration’s drugs center CDER, is to become the agency’s deputy commissioner for global regulatory operations and policy, effective 13 January1.